Ambu A/S/€AMBUB
06:30
16:10
01:45
11:25
21:00
1D1W1MYTD1Y5YMAX
About Ambu A/S
Ambu A/S is a Danish company operating in the medical device industry, primarily involved in the development, manufacturing, and marketing of innovative healthcare solutions. The company's key products include single-use endoscopes, anesthesia devices, and patient monitoring and diagnostic solutions. Ambu was founded in 1937 and is headquartered in Ballerup, Denmark. It is known for its focus on single-use devices, which help reduce the risk of cross-contamination and improve efficiency in hospitals and clinics worldwide. The company's strategic positioning emphasizes innovation in medical technology and a strong commitment to addressing healthcare challenges globally.
Ticker
€AMBUB
Sector
Primary listing
XGAT
Employees
5,384
Headquarters
Ballerup, Denmark
Website
Ambu A/S Metrics
BasicAdvanced
€3.1B
38.10
€0.31
1.55
€0.05
0.47%
Price and volume
Market cap
€3.1B
Beta
1.55
52-week high
€19.30
52-week low
€10.78
Average daily volume
160K
Dividend rate
€0.05
Financial strength
Current ratio
2.724
Quick ratio
1.53
Long term debt to equity
7.738
Total debt to equity
9.064
Dividend payout ratio (TTM)
16.75%
Interest coverage (TTM)
26.13%
Profitability
EBITDA (TTM)
124.241
Gross margin (TTM)
60.18%
Net profit margin (TTM)
10.09%
Operating margin (TTM)
12.99%
Effective tax rate (TTM)
19.34%
Revenue per employee (TTM)
€149,940
Management effectiveness
Return on assets (TTM)
6.61%
Return on equity (TTM)
10.47%
Valuation
Price to earnings (TTM)
38.1
Price to revenue (TTM)
3.834
Price to book
3.84
Price to tangible book (TTM)
8.31
Price to free cash flow (TTM)
56.876
Free cash flow yield (TTM)
1.76%
Free cash flow per share (TTM)
0.204
Dividend yield (TTM)
0.47%
Forward dividend yield
0.47%
Growth
Revenue change (TTM)
11.98%
Earnings per share change (TTM)
159.09%
3-year revenue growth (CAGR)
10.75%
10-year revenue growth (CAGR)
12.32%
3-year earnings per share growth (CAGR)
83.97%
10-year earnings per share growth (CAGR)
14.06%
10-year dividend per share growth (CAGR)
7.99%
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Market data provided by CBOE Europe and Deutsche Börse.
Capital at risk
Upcoming events
No upcoming events
FAQs
What’s the current market cap for Ambu A/S stock?
Ambu A/S (AMBUB) has a market cap of €3.1B as of December 15, 2025.
What is the P/E ratio for Ambu A/S stock?
The price to earnings (P/E) ratio for Ambu A/S (AMBUB) stock is 38.1 as of December 15, 2025.
Does Ambu A/S stock pay dividends?
Yes, the Ambu A/S (AMBUB) stock pays dividends to shareholders. As of December 15, 2025, the dividend rate is €0.05488 and the yield is 0.47%. Ambu A/S has a payout ratio of 16.75% on a trailing twelve-month basis.
When is the next Ambu A/S dividend payment date?
The next Ambu A/S (AMBUB) dividend payment date is unconfirmed.
What is the beta indicator for Ambu A/S?
Ambu A/S (AMBUB) has a beta rating of 1.55. This means that it is more volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 2 would indicate the stock moves twice as much as the market.